Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy
- PMID: 1763060
- PMCID: PMC53155
- DOI: 10.1073/pnas.88.24.11460
Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy
Abstract
The results obtained in this study establish that liposome formulations incorporating a synthetic polyethylene glycol-derivatized phospholipid have a pronounced effect on liposome tissue distribution and can produce a large increase in the pharmacological efficacy of encapsulated antitumor drugs. This effect is substantially greater than that observed previously with conventional liposomes and is associated with a more than 5-fold prolongation of liposome circulation time in blood, a marked decrease in uptake by tissues such as liver and spleen, and a corresponding increased accumulation in implanted tumors. These and other properties described here have expanded considerably the prospects of liposomes as an effective carrier system for a variety of pharmacologically active macromolecules.
Similar articles
-
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma.Cancer Res. 1992 Dec 15;52(24):6774-81. Cancer Res. 1992. PMID: 1458465
-
Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes.Cancer Res. 1992 Feb 15;52(4):891-6. Cancer Res. 1992. PMID: 1737351
-
Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid.Int J Cancer. 1992 May 8;51(2):302-9. doi: 10.1002/ijc.2910510221. Int J Cancer. 1992. PMID: 1568796
-
Tailoring liposomes for cancer drug delivery: from the bench to the clinic.Ann Biol Clin (Paris). 1993;51(9):811-3. Ann Biol Clin (Paris). 1993. PMID: 8166395 Review.
-
Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours.Drugs. 1997;54 Suppl 4:15-21. doi: 10.2165/00003495-199700544-00005. Drugs. 1997. PMID: 9361957 Review.
Cited by
-
Clinical Application of Cytokines in Cancer Immunotherapy.Drug Des Devel Ther. 2021 May 27;15:2269-2287. doi: 10.2147/DDDT.S308578. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34079226 Free PMC article. Review.
-
Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy.J Nanobiotechnology. 2021 Jun 15;19(1):184. doi: 10.1186/s12951-021-00931-3. J Nanobiotechnology. 2021. PMID: 34130695 Free PMC article.
-
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells.Int J Nanomedicine. 2016 Apr 5;11:1413-25. doi: 10.2147/IJN.S95850. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27103799 Free PMC article.
-
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.Eur J Nucl Med Mol Imaging. 2006 Oct;33(10):1196-205. doi: 10.1007/s00259-006-0139-x. Epub 2006 Jun 9. Eur J Nucl Med Mol Imaging. 2006. PMID: 16763815
-
PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment.PLoS One. 2019 Jul 22;14(7):e0219995. doi: 10.1371/journal.pone.0219995. eCollection 2019. PLoS One. 2019. PMID: 31329627 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical